- Training
- 90 Minutes
Global
- Report
- June 2023
- 180 Pages
Global
From €3346EUR$3,750USD£2,950GBP
- Training
- October 2021
- 1 Day
Latin America
From €1159EUR$1,299USD£1,022GBP
- Training
- 90 Minutes
Global
- Training
- 90 Minutes
Latin America
- Report
- December 2022
- 50 Pages
Global
From €1785EUR$2,000USD£1,574GBP
- Report
- October 2022
- 74 Pages
Global
From €1785EUR$2,000USD£1,574GBP
- Webinar
- May 2023
- 90 Minutes
Argentina, Brazil, ... Argentina, Brazil, Mexico, Latin America
From €170EUR$190USD£149GBP
Bioequivalence is a term used in biotechnology to describe the similarity between two pharmaceutical products. It is used to assess the interchangeability of two products, such as generic and brand-name drugs, and to ensure that they have the same therapeutic effect. Bioequivalence studies are conducted to compare the pharmacokinetic properties of two products, such as their absorption, distribution, metabolism, and excretion. The results of these studies are used to determine whether the two products are therapeutically equivalent and can be used interchangeably.
The bioequivalence market is a rapidly growing sector of the biotechnology industry. It is driven by the increasing demand for generic drugs, as well as the need for regulatory compliance. Companies in this market provide services such as bioequivalence studies, pharmacokinetic analysis, and regulatory consulting.
Some companies in the bioequivalence market include Parexel, Covance, Quintiles, and PPD. Show Less Read more